Enzyme activity effects of N-terminal His-tag attached to catalytic sub-unit of phosphoinositide-3-kinase

por Dickson, James M. J., Lee, Woo-Jeong, Shepherd, Peter R., Buchanan, Christina M.
Publicado 2013

Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status

por Pak, Min Gyoung, Lee, Chang-Hun, Lee, Woo-Jeong, Shin, Dong-Hoon, Roh, Mee-Sook
Publicado 2015

Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer

por Kim, Ji Yeon, Lee, Woo Jeong, Park, Ha Young, Kim, Ahrong, Shin, Dong Hoon, Lee, Chang Hun
Publicado 2018

Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity

por Buchanan, Christina M., Dickson, James M. J., Lee, Woo-Jeong, Guthridge, Mark A., Kendall, Jackie D., Shepherd, Peter R.
Publicado 2013

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

por Jamieson, Stephen, Flanagan, Jack U., Kolekar, Sharada, Buchanan, Christina, Kendall, Jackie D., Lee, Woo-Jeong, Rewcastle, Gordon W., Denny, William A., Singh, Ripudaman, Dickson, James, Baguley, Bruce C., Shepherd, Peter R.
Publicado 2011

Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors

por Rewcastle, Gordon W, Kolekar, Sharada, Buchanan, Christina M, Gamage, Swarna A, Giddens, Anna C, Tsang, Kit Y, Kendall, Jackie D, Singh, Ripudaman, Lee, Woo-Jeong, Smith, Greg C, Han, Weiping, Matthews, David J, Denny, William A, Shepherd, Peter R, Jamieson, Stephen M.F
Publicado 2017